Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

48.79
Delayed Data
As of Sep 25
 -0.43 / -0.87%
Today’s Change
30.89
Today|||52-Week Range
49.45
+36.06%
Year-to-Date

Today’s Trading

Previous close49.22
Today’s open49.22
Day’s range48.72 - 49.40
Volume1,019,247
Average volume (3 months)1,791,806
Market cap$96.8B
Dividend yield1.94%
Data as of 4:02pm ET, 09/25/2017

Growth & Valuation

Earnings growth (last year)+10.80%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.50%
Revenue growth (last year)+3.81%
P/E ratio3.2
Price/Sales5.48
Price/Book19.20

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co+0.73+0.87%
ABTAbbott Laboratories+0.10+0.19%
GSKGlaxoSmithKline+0.07+0.17%
BMYBristol-Myers Squibb-0.17-0.27%
Data as of 4:02pm ET, 09/25/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)$0.60
Annual revenue (last year)$16.6B
Annual profit (last year)$5.6B
Net profit margin33.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Fruergaard Jørgensen
Executive Vice President-
International Operations
Maziar Mike Doustdar
Corporate headquarters
Bagsværd, Capital Region

Forecasts